Teva Pharmaceutical Industries says it'll close Bucks Co. plant in 2017 | Business News | wfmz.com
Teva shares surge after announcing global opioid settlement
Teva profit plummets, stock slides | Ctech
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Stock Plunges On Flat Sales, Earnings Disappointment | Investor's Business Daily
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Teva Pharmaceuticals (@TevaUSA) / Twitter
Layoffs To Deepen As Teva Unveils New Structure And Leadership Changes - Pharmaceutical Processing World
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Clinics Across Florida, New Jersey & California Advancing Mental Health in Underserved Communities - Awarded Funding from Teva Pharmaceuticals, Direct Relief and NAFC | The National Association of Free & Charitable Clinics
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Is Teva Pharmaceutical Industries (NYSE:TEVA) A Risky Investment? - Simply Wall St News
Should You Sell Teva Pharmaceutical Industries Ltd (TEVA) Stock Friday Morning?
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva looks to amp up research collaborations, CEO says
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
